Boston Scientific Corporation (BSX.F)
EUR 93.0
(4.49%)
EUR 93.0
(4.49%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 9.49 Billion USD | 2.26% |
| 2022 | 9.28 Billion USD | -1.79% |
| 2021 | 9.45 Billion USD | -0.92% |
| 2020 | 9.53 Billion USD | -7.18% |
| 2019 | 10.27 Billion USD | 46.19% |
| 2018 | 7.03 Billion USD | 26.03% |
| 2017 | 5.57 Billion USD | 1.71% |
| 2016 | 5.48 Billion USD | -3.4% |
| 2015 | 5.67 Billion USD | 33.2% |
| 2014 | 4.26 Billion USD | 0.52% |
| 2013 | 4.24 Billion USD | -0.38% |
| 2012 | 4.25 Billion USD | -0.12% |
| 2011 | 4.26 Billion USD | -21.64% |
| 2010 | 5.43 Billion USD | -8.11% |
| 2009 | 5.91 Billion USD | -12.26% |
| 2008 | 6.74 Billion USD | -17.63% |
| 2007 | 8.18 Billion USD | -8.01% |
| 2006 | 8.9 Billion USD | 340.69% |
| 2005 | 2.02 Billion USD | -14.66% |
| 2004 | 2.36 Billion USD | 37.22% |
| 2003 | 1.72 Billion USD | 84.49% |
| 2002 | 935 Million USD | -22.34% |
| 2001 | 1.2 Billion USD | 44.36% |
| 2000 | 834 Million USD | -34.74% |
| 1999 | 1.27 Billion USD | -46.56% |
| 1998 | 2.39 Billion USD | 384.56% |
| 1997 | 493.5 Million USD | 71.47% |
| 1996 | 287.8 Million USD | 305.35% |
| 1995 | 71 Million USD | 64.73% |
| 1994 | 43.1 Million USD | 21.41% |
| 1993 | 35.5 Million USD | 36.02% |
| 1992 | 26.1 Million USD | 3.57% |
| 1991 | 25.2 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 10.93 Billion USD | -0.59% |
| 2024 Q1 | 11 Billion USD | 15.9% |
| 2023 Q4 | 9.49 Billion USD | 2.08% |
| 2023 Q1 | 9.36 Billion USD | 0.89% |
| 2023 Q3 | 9.29 Billion USD | -1.64% |
| 2023 FY | 9.49 Billion USD | 2.26% |
| 2023 Q2 | 9.45 Billion USD | 0.95% |
| 2022 Q3 | 8.93 Billion USD | -4.21% |
| 2022 Q4 | 9.28 Billion USD | 3.9% |
| 2022 FY | 9.28 Billion USD | -1.79% |
| 2022 Q1 | 9.68 Billion USD | 2.45% |
| 2022 Q2 | 9.32 Billion USD | -3.68% |
| 2021 Q1 | 9.44 Billion USD | -1.01% |
| 2021 Q2 | 9.46 Billion USD | 0.22% |
| 2021 Q3 | 9.45 Billion USD | -0.05% |
| 2021 Q4 | 9.45 Billion USD | -0.08% |
| 2021 FY | 9.45 Billion USD | -0.92% |
| 2020 Q1 | 10.59 Billion USD | 3.11% |
| 2020 FY | 9.53 Billion USD | -7.18% |
| 2020 Q4 | 9.53 Billion USD | 2.23% |
| 2020 Q3 | 9.33 Billion USD | -4.68% |
| 2020 Q2 | 9.78 Billion USD | -7.62% |
| 2019 Q2 | 9.52 Billion USD | 3.4% |
| 2019 FY | 10.27 Billion USD | 46.19% |
| 2019 Q3 | 10.87 Billion USD | 14.15% |
| 2019 Q4 | 10.27 Billion USD | -5.48% |
| 2019 Q1 | 9.21 Billion USD | 31.04% |
| 2018 FY | 7.03 Billion USD | 26.03% |
| 2018 Q1 | 5.73 Billion USD | 2.72% |
| 2018 Q2 | 6.46 Billion USD | 12.76% |
| 2018 Q3 | 6.59 Billion USD | 2.12% |
| 2018 Q4 | 7.03 Billion USD | 6.55% |
| 2017 Q3 | 5.68 Billion USD | -2.62% |
| 2017 FY | 5.57 Billion USD | 1.71% |
| 2017 Q4 | 5.57 Billion USD | -1.83% |
| 2017 Q2 | 5.83 Billion USD | 5.82% |
| 2017 Q1 | 5.51 Billion USD | 0.55% |
| 2016 Q1 | 5.67 Billion USD | 0.0% |
| 2016 FY | 5.48 Billion USD | -3.4% |
| 2016 Q3 | 5.42 Billion USD | -0.04% |
| 2016 Q2 | 5.42 Billion USD | -4.4% |
| 2016 Q4 | 5.48 Billion USD | 1.09% |
| 2015 Q3 | 5.85 Billion USD | 14.61% |
| 2015 Q4 | 5.67 Billion USD | -3.11% |
| 2015 FY | 5.67 Billion USD | 33.2% |
| 2015 Q1 | 4.26 Billion USD | 0.14% |
| 2015 Q2 | 5.11 Billion USD | 19.78% |
| 2014 Q4 | 4.26 Billion USD | 0.24% |
| 2014 Q2 | 4.25 Billion USD | 0.14% |
| 2014 Q3 | 4.25 Billion USD | -0.07% |
| 2014 FY | 4.26 Billion USD | 0.52% |
| 2014 Q1 | 4.24 Billion USD | 0.21% |
| 2013 Q1 | 4.25 Billion USD | -0.05% |
| 2013 Q4 | 4.24 Billion USD | -0.21% |
| 2013 Q3 | 4.24 Billion USD | -0.07% |
| 2013 Q2 | 4.25 Billion USD | -0.05% |
| 2013 FY | 4.24 Billion USD | -0.38% |
| 2012 Q3 | 4.25 Billion USD | -0.05% |
| 2012 Q2 | 4.25 Billion USD | -0.05% |
| 2012 Q1 | 4.25 Billion USD | -0.05% |
| 2012 FY | 4.25 Billion USD | -0.12% |
| 2012 Q4 | 4.25 Billion USD | 0.02% |
| 2011 Q1 | 4.92 Billion USD | -9.45% |
| 2011 FY | 4.26 Billion USD | -21.64% |
| 2011 Q4 | 4.26 Billion USD | -0.05% |
| 2011 Q3 | 4.26 Billion USD | 1.48% |
| 2011 Q2 | 4.2 Billion USD | -14.68% |
| 2010 Q3 | 6.03 Billion USD | 0.07% |
| 2010 Q2 | 6.03 Billion USD | 1.89% |
| 2010 Q1 | 5.92 Billion USD | 0.05% |
| 2010 FY | 5.43 Billion USD | -8.11% |
| 2010 Q4 | 5.43 Billion USD | -9.92% |
| 2009 Q2 | 6.25 Billion USD | 0.05% |
| 2009 Q4 | 5.91 Billion USD | -1.86% |
| 2009 FY | 5.91 Billion USD | -12.26% |
| 2009 Q3 | 6.03 Billion USD | -3.52% |
| 2009 Q1 | 6.24 Billion USD | -7.38% |
| 2008 Q4 | 6.74 Billion USD | -3.66% |
| 2008 FY | 6.74 Billion USD | -17.63% |
| 2008 Q1 | 7.56 Billion USD | -7.58% |
| 2008 Q2 | 7.28 Billion USD | -3.74% |
| 2008 Q3 | 7 Billion USD | -3.9% |
| 2007 FY | 8.18 Billion USD | -8.01% |
| 2007 Q4 | 8.18 Billion USD | 0.39% |
| 2007 Q1 | 8.9 Billion USD | 0.03% |
| 2007 Q2 | 8.9 Billion USD | -0.01% |
| 2007 Q3 | 8.15 Billion USD | -8.39% |
| 2006 FY | 8.9 Billion USD | 340.69% |
| 2006 Q1 | 2.64 Billion USD | 30.79% |
| 2006 Q2 | 8.89 Billion USD | 236.79% |
| 2006 Q3 | 8.89 Billion USD | 0.0% |
| 2006 Q4 | 8.9 Billion USD | 0.04% |
| 2005 Q1 | 1.54 Billion USD | -34.73% |
| 2005 Q3 | 2.51 Billion USD | 22.28% |
| 2005 Q2 | 2.05 Billion USD | 33.07% |
| 2005 Q4 | 2.02 Billion USD | -19.65% |
| 2005 FY | 2.02 Billion USD | -14.66% |
| 2004 Q1 | 1.67 Billion USD | -2.9% |
| 2004 FY | 2.36 Billion USD | 37.22% |
| 2004 Q3 | 2.49 Billion USD | -2.27% |
| 2004 Q4 | 2.36 Billion USD | -5.17% |
| 2004 Q2 | 2.55 Billion USD | 52.48% |
| 2003 Q2 | 1.32 Billion USD | 5.92% |
| 2003 FY | 1.72 Billion USD | 84.49% |
| 2003 Q3 | 1.64 Billion USD | 23.77% |
| 2003 Q4 | 1.72 Billion USD | 5.18% |
| 2003 Q1 | 1.25 Billion USD | 33.8% |
| 2002 Q3 | 1.1 Billion USD | -5.38% |
| 2002 Q4 | 935 Million USD | -15.61% |
| 2002 Q1 | 1.24 Billion USD | 3.24% |
| 2002 Q2 | 1.17 Billion USD | -5.79% |
| 2002 FY | 935 Million USD | -22.34% |
| 2001 Q2 | 1.12 Billion USD | 23.79% |
| 2001 Q1 | 908 Million USD | 8.87% |
| 2001 Q3 | 1.2 Billion USD | 7.38% |
| 2001 Q4 | 1.2 Billion USD | -0.25% |
| 2001 FY | 1.2 Billion USD | 44.36% |
| 2000 FY | 834 Million USD | -34.74% |
| 2000 Q2 | 1.01 Billion USD | -14.55% |
| 2000 Q1 | 1.18 Billion USD | -7.51% |
| 2000 Q4 | 834 Million USD | -3.02% |
| 2000 Q3 | 860 Million USD | -14.85% |
| 1999 Q1 | 2.28 Billion USD | -4.36% |
| 1999 Q3 | 1.32 Billion USD | -15.55% |
| 1999 Q4 | 1.27 Billion USD | -3.18% |
| 1999 FY | 1.27 Billion USD | -46.56% |
| 1999 Q2 | 1.56 Billion USD | -31.66% |
| 1998 Q4 | 2.39 Billion USD | -9.35% |
| 1998 FY | 2.39 Billion USD | 384.56% |
| 1998 Q1 | 572.6 Million USD | 16.03% |
| 1998 Q2 | 578.3 Million USD | 1.0% |
| 1998 Q3 | 2.63 Billion USD | 356.15% |
| 1997 Q3 | 415.8 Million USD | 18.7% |
| 1997 Q4 | 493.5 Million USD | 18.69% |
| 1997 FY | 493.5 Million USD | 71.47% |
| 1997 Q1 | 270 Million USD | -6.18% |
| 1997 Q2 | 350.3 Million USD | 29.74% |
| 1996 Q4 | 287.8 Million USD | 27.35% |
| 1996 FY | 287.8 Million USD | 305.35% |
| 1996 Q1 | 156.3 Million USD | 120.14% |
| 1996 Q2 | 260.7 Million USD | 66.79% |
| 1996 Q3 | 226 Million USD | -13.31% |
| 1995 Q4 | 71 Million USD | 88.33% |
| 1995 Q3 | 37.7 Million USD | -41.0% |
| 1995 Q2 | 63.9 Million USD | -15.25% |
| 1995 FY | 71 Million USD | 64.73% |
| 1995 Q1 | 75.4 Million USD | 74.94% |
| 1994 FY | 43.1 Million USD | 21.41% |
| 1994 Q4 | 43.1 Million USD | 8.56% |
| 1994 Q3 | 39.7 Million USD | 13.43% |
| 1994 Q2 | 35 Million USD | 9.38% |
| 1994 Q1 | 32 Million USD | -9.86% |
| 1993 Q1 | 26.4 Million USD | 1.15% |
| 1993 Q2 | 30.9 Million USD | 17.05% |
| 1993 FY | 35.5 Million USD | 36.02% |
| 1993 Q4 | 35.5 Million USD | 0.0% |
| 1993 Q3 | 35.5 Million USD | 14.89% |
| 1992 Q1 | 42.7 Million USD | 69.44% |
| 1992 Q3 | 27.7 Million USD | 0.36% |
| 1992 Q4 | 26.1 Million USD | -5.78% |
| 1992 FY | 26.1 Million USD | 3.57% |
| 1992 Q2 | 27.6 Million USD | -35.36% |
| 1991 Q4 | 25.2 Million USD | 0.0% |
| 1991 FY | 25.2 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| aap Implantate AG | 5.29 Million EUR | -179265.079% |
| Drägerwerk AG & Co. KGaA | 471.38 Million EUR | -1913.649% |
| Drägerwerk AG & Co. KGaA | 471.38 Million EUR | -1913.649% |
| elexxion AG | 4.07 Million EUR | -232737.381% |
| Eckert & Ziegler Strahlen- und Medizintechnik AG | 56.3 Million EUR | -16758.483% |
| Geratherm Medical AG | 7.23 Million EUR | -131169.095% |
| Koninklijke Philips N.V. | 7.61 Billion EUR | -24.681% |
| Stratec SE | 141.37 Million EUR | -6614.248% |
| Siemens Healthineers AG | 633 Million EUR | -1399.526% |